Gout PW - Search Results

1

Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy.

Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR, Wang YZ. Doxsee DW, et al. Among authors: gout pw. Prostate. 2007 Feb 1;67(2):162-71. doi: 10.1002/pros.20508. Prostate. 2007. PMID: 17075799

2

Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug.

Gout PW, Buckley AR, Simms CR, Bruchovsky N. Gout PW, et al. Leukemia. 2001 Oct;15(10):1633-40. doi: 10.1038/sj.leu.2402238. Leukemia. 2001. PMID: 11587223

3

The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance.

Lo M, Ling V, Wang YZ, Gout PW. Lo M, et al. Among authors: gout pw. Br J Cancer. 2008 Aug 5;99(3):464-72. doi: 10.1038/sj.bjc.6604485. Epub 2008 Jul 22. Br J Cancer. 2008. PMID: 18648370 Free PMC article.

4

The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases.

Lo M, Wang YZ, Gout PW. Lo M, et al. Among authors: gout pw. J Cell Physiol. 2008 Jun;215(3):593-602. doi: 10.1002/jcp.21366. J Cell Physiol. 2008. PMID: 18181196 Review.

5

The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.

Guan J, Lo M, Dockery P, Mahon S, Karp CM, Buckley AR, Lam S, Gout PW, Wang YZ. Guan J, et al. Among authors: gout pw. Cancer Chemother Pharmacol. 2009 Aug;64(3):463-72. doi: 10.1007/s00280-008-0894-4. Epub 2008 Dec 24. Cancer Chemother Pharmacol. 2009. PMID: 19104813

6

Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.

Lin D, Bayani J, Wang Y, Sadar MD, Yoshimoto M, Gout PW, Squire JA, Wang Y. Lin D, et al. Among authors: gout pw. Prostate. 2010 Nov 1;70(15):1636-44. doi: 10.1002/pros.21199. Prostate. 2010. PMID: 20564316

7

Use of irinotecan for treatment of small cell carcinoma of the prostate.

Tung WL, Wang Y, Gout PW, Liu DM, Gleave M, Wang Y. Tung WL, et al. Among authors: gout pw. Prostate. 2011 May 15;71(7):675-81. doi: 10.1002/pros.21283. Epub 2010 Oct 14. Prostate. 2011. PMID: 20949523

8

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ. Wang Y, et al. Among authors: gout pw. Lab Invest. 2005 Nov;85(11):1392-404. doi: 10.1038/labinvest.3700335. Lab Invest. 2005. PMID: 16155594 Free article.

9

Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells.

Gout PW, Kang YJ, Buckley DJ, Bruchovsky N, Buckley AR. Gout PW, et al. Leukemia. 1997 Aug;11(8):1329-37. doi: 10.1038/sj.leu.2400739. Leukemia. 1997. PMID: 9264389

10

Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer.

Lo M, Ling V, Low C, Wang YZ, Gout PW. Lo M, et al. Among authors: gout pw. Curr Oncol. 2010 Jun;17(3):9-16. doi: 10.3747/co.v17i3.485. Curr Oncol. 2010. PMID: 20567622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters